Clinical and Translational Medicine (Apr 2022)
HER2/PD1 bispecific antibody in IgG4 subclass with superior anti‐tumour activities
- Wendi Chu,
- Hui Xu,
- Yanfei Wang,
- Yongle Xie,
- Yi‐Li Chen,
- Xiaorong Tan,
- Chenghao Huang,
- Guifeng Wang,
- Qi Wang,
- Wenxin Luo,
- Ningshao Xia,
- Meiyu Geng,
- Zuoquan Xie,
- Chunhe Wang
Affiliations
- Wendi Chu
- Biotherapeutics Discovery Research Center Shanghai Institute of Materia Medica, Chinese Academy of Sciences Bldg#1, 720 Cai Lun Road Shanghai 200126 PR China
- Hui Xu
- State Key Laboratory of Drug Research Shanghai Institute of Materia Medica, Chinese Academy of Sciences 555 Zu Chong Zhi Road Shanghai 200126 PR China
- Yanfei Wang
- Biotherapeutics Discovery Research Center Shanghai Institute of Materia Medica, Chinese Academy of Sciences Bldg#1, 720 Cai Lun Road Shanghai 200126 PR China
- Yongle Xie
- State Key Laboratory of Drug Research Shanghai Institute of Materia Medica, Chinese Academy of Sciences 555 Zu Chong Zhi Road Shanghai 200126 PR China
- Yi‐Li Chen
- Shanghai Mabstone Biotechnology Ltd Shanghai PR China
- Xiaorong Tan
- Biotherapeutics Discovery Research Center Shanghai Institute of Materia Medica, Chinese Academy of Sciences Bldg#1, 720 Cai Lun Road Shanghai 200126 PR China
- Chenghao Huang
- State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics School of Public Health and School of Life Science Xiamen University Xiamen PR China
- Guifeng Wang
- Biotherapeutics Discovery Research Center Shanghai Institute of Materia Medica, Chinese Academy of Sciences Bldg#1, 720 Cai Lun Road Shanghai 200126 PR China
- Qi Wang
- Biotherapeutics Discovery Research Center Shanghai Institute of Materia Medica, Chinese Academy of Sciences Bldg#1, 720 Cai Lun Road Shanghai 200126 PR China
- Wenxin Luo
- State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics School of Public Health and School of Life Science Xiamen University Xiamen PR China
- Ningshao Xia
- State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics School of Public Health and School of Life Science Xiamen University Xiamen PR China
- Meiyu Geng
- State Key Laboratory of Drug Research Shanghai Institute of Materia Medica, Chinese Academy of Sciences 555 Zu Chong Zhi Road Shanghai 200126 PR China
- Zuoquan Xie
- State Key Laboratory of Drug Research Shanghai Institute of Materia Medica, Chinese Academy of Sciences 555 Zu Chong Zhi Road Shanghai 200126 PR China
- Chunhe Wang
- Biotherapeutics Discovery Research Center Shanghai Institute of Materia Medica, Chinese Academy of Sciences Bldg#1, 720 Cai Lun Road Shanghai 200126 PR China
- DOI
- https://doi.org/10.1002/ctm2.791
- Journal volume & issue
-
Vol. 12,
no. 4
pp. n/a – n/a
Abstract
No abstracts available.
